These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 37259073)

  • 21. Non-disclosure of drug injection practices as a barrier to HCV testing: results from the PrebupIV community-based research study.
    Anwar I; Donadille C; Protopopescu C; Michels D; Herin J; Pladys A; Bader D; Carrieri P; Roux P
    Harm Reduct J; 2023 Jul; 20(1):98. PubMed ID: 37516889
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hepatitis C Virus Seroprevalence in Persons Who Inject Drugs in Korea, 2012-2022: A Multicenter, Retrospective Study.
    Kim J; Choi GH; Jang OJ; Chon Y; Cho SN; Kwon D; Jeong SH
    J Korean Med Sci; 2023 Dec; 38(48):e357. PubMed ID: 38084024
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Engaging people who inject drugs in hepatitis C virus testing and prevention through community-based outreach, in Sydney, Australia.
    Coupland H; White B; Bates A; Park JN; Iversen J; Maher L
    Drug Alcohol Rev; 2019 Feb; 38(2):177-184. PubMed ID: 30652363
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Short and sporadic injecting cessation episodes as predictors of incident hepatitis C virus infection: findings from a cohort study of people who inject drugs in Montréal, Canada.
    Fortier E; Artenie AA; Zang G; Jutras-Aswad D; Roy É; Grebely J; Bruneau J
    Addiction; 2019 Aug; 114(8):1495-1503. PubMed ID: 30957310
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Case-finding for hepatitis C in primary care: a mixed-methods service evaluation.
    Datta S; Horwood J; Hickman M; Sharp D
    Br J Gen Pract; 2014 Feb; 64(619):e67-74. PubMed ID: 24567619
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recommendations for the management of hepatitis C virus infection among people who inject drugs.
    Robaeys G; Grebely J; Mauss S; Bruggmann P; Moussalli J; De Gottardi A; Swan T; Arain A; Kautz A; Stöver H; Wedemeyer H; Schaefer M; Taylor L; Backmund M; Dalgard O; Prins M; Dore GJ;
    Clin Infect Dis; 2013 Aug; 57 Suppl 2():S129-37. PubMed ID: 23884061
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Peer outreach point-of-care testing as a bridge to hepatitis C care for people who inject drugs in Toronto, Canada.
    Broad J; Mason K; Guyton M; Lettner B; Matelski J; Powis J
    Int J Drug Policy; 2020 Jun; 80():102755. PubMed ID: 32416538
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Utility of a one-step screening and diagnosis strategy for viremic HCV infection among people who inject drugs in Catalonia.
    Saludes V; Antuori A; Folch C; González N; Ibáñez N; Majó X; Colom J; Matas L; Casabona J; Martró E;
    Int J Drug Policy; 2019 Dec; 74():236-245. PubMed ID: 31706159
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Exploring hepatitis C virus testing and treatment engagement over time in Melbourne, Australia: a study protocol for a longitudinal cohort study (EC-Experience Cohort study).
    O'Keefe D; Gunn J; Ryan K; Djordjevic F; Kerr P; Gold J; Elsum I; Layton C; Chan K; Dietze P; Higgs P; Doyle J; Stoové MA; Hellard M; Pedrana AE
    BMJ Open; 2022 Jan; 12(1):e057618. PubMed ID: 34983773
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Motivations, facilitators and barriers to accessing hepatitis C treatment among people who inject drugs in two South African cities.
    Versfeld A; McBride A; Scheibe A; Spearman CW
    Harm Reduct J; 2020 Jun; 17(1):39. PubMed ID: 32522210
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Barriers to accessing sterile injecting equipment for people who inject drugs: An integrative review.
    Lawson E; Walthall H
    J Clin Nurs; 2023 Aug; 32(15-16):4502-4514. PubMed ID: 36068712
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Need for integration of hepatitis C (HCV) services in community-based settings for people who inject drugs: results from a global values and preferences survey.
    Di Ciaccio M; Villes V; Perfect C; El Kaim JL; Donatelli M; James C; Easterbrook P; Delabre RM
    Harm Reduct J; 2023 Feb; 20(1):15. PubMed ID: 36759855
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sexual behaviour as a risk factor for hepatitis C virus infection among people who inject drugs in Montreal, Canada.
    Jacka B; Roy É; Høj S; Minoyan N; Artenie AA; Zang G; Jutras-Aswad D; Bruneau J
    J Viral Hepat; 2019 Dec; 26(12):1413-1422. PubMed ID: 31433888
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prescription opioid injection among young people who inject drugs in New York City: a mixed-methods description and associations with hepatitis C virus infection and overdose.
    Mateu-Gelabert P; Guarino H; Zibbell JE; Teubl J; Fong C; Goodbody E; Edlin B; Salvati C; Friedman SR
    Harm Reduct J; 2020 Mar; 17(1):22. PubMed ID: 32228700
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment cascade for hepatitis C virus in young adult people who inject drugs in San Francisco: Low number treated.
    Morris MD; Mirzazadeh A; Evans JL; Briceno A; Coffin P; Hahn JA; Page KA
    Drug Alcohol Depend; 2019 May; 198():133-135. PubMed ID: 30921649
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Estimating the cascade of hepatitis C testing, care and treatment among people who inject drugs in Australia.
    Iversen J; Grebely J; Catlett B; Cunningham P; Dore GJ; Maher L
    Int J Drug Policy; 2017 Sep; 47():77-85. PubMed ID: 28578863
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Eligibility of persons who inject drugs for treatment of hepatitis C virus infection.
    Arain A; Robaeys G
    World J Gastroenterol; 2014 Sep; 20(36):12722-33. PubMed ID: 25278674
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High prevalence of hepatitis C virus infection and low level of awareness among people who recently started injecting drugs in a cross-sectional study in Germany, 2011-2014: missed opportunities for hepatitis C testing.
    Enkelmann J; Gassowski M; Nielsen S; Wenz B; Roß S; Marcus U; Bremer V; Zimmermann R;
    Harm Reduct J; 2020 Jan; 17(1):7. PubMed ID: 31924208
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Drug use-related stigma, safer injection norms, and hepatitis C infection among a network-based sample of young people who inject drugs.
    Williams LD; Mackesy-Amiti ME; Latkin C; Boodram B
    Drug Alcohol Depend; 2021 Apr; 221():108626. PubMed ID: 33689967
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Barriers and facilitators of hepatitis C screening among people who inject drugs: a multi-city, mixed-methods study.
    Barocas JA; Brennan MB; Hull SJ; Stokes S; Fangman JJ; Westergaard RP
    Harm Reduct J; 2014 Jan; 11():1. PubMed ID: 24422784
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.